Enlarge / Heather Bresch, CEO of Mylan NV, refers to a chart while speaking during a House Oversight and Government Reform Committee hearing in Washington, DC on Wednesday, Sept. 21, 2016. (credit: Getty | Bloomberg)
A whopping 83 percent of Mylan shareholders voted down the company’s astronomical executive compensation packages. But a majority of shareholders still supports most of the company’s beleaguered directors, according to fresh filings with the US Securities and Exchange Commission.
Ars reported the general outcomes of the shareholder votes that took place last week at an annual meeting in Amsterdam. The vote was closely watched after a group of shareholders, disgruntled by the EpiPen pricing scandal and executive pay, began campaigning to reject executive pay plans and oust the board—something that requires a two-thirds majority under Mylan’s governance rules. Though shareholders did not unseat the incumbent board members, Mylan declined to reveal the vote tallies.
Those tallies, however, were revealed yesterday in a public filing with the SEC—and they’ve reignited calls for resignations and reform.
Read 9 remaining paragraphs | Comments
